Irina Kadiyala

Senior Director & Head, Heme Process Development • Vertex Cell and Gene Therapies

Irina Kadiyala has more than 22 years of industrial experience and in the current position, she heads the Heme Process Development group at Vertex Cell Gene Therapies. She is responsible for enabling process validation studies and their execution relying on her expertise in aseptic cell manufacturing.

Irina has Ph.D. in Biophysics.

Also Speaking

Yara Park

Professor and Director • University of North Carolina

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Mathias Svahn

Co-Founder • NextCell Pharma

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.